

Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
PFE | NYSE | USD | Real-time | |
PFE | Mexico | MXN | Delayed | |
PFE | Stockholm | SEK | Real-time | |
PFE | Hamburg | EUR | Delayed | |
PFE | TradeGate | EUR | Delayed | |
PFE | Frankfurt | EUR | Delayed | |
PFE | Xetra | EUR | Delayed | |
PFE | Santiago | USD | Delayed | |
PFE | Buenos Aires | ARS | Delayed | |
PFIZ34 | BM&FBovespa | BRL | Delayed | |
PFE | Vienna | EUR | Delayed | |
PFE-RM | Moscow | RUB | Real-time | |
PFE_KZ | KASE | USD | Delayed | |
PFE | Colombia | COP | Delayed | |
PFE | Lima | USD | Delayed |
By Manas Mishra and Michael Erman (Reuters) -The U.S. Centers for Disease Control and Prevention (CDC) on Thursday recommended the COVID-19 vaccine booster for children ages 5 to 11 after an advisory...
By Michael Erman (Reuters) - The U.S. National Institutes of Health is in talks with Pfizer Inc (NYSE:PFE) about studying whether a longer course of the drugmaker's COVID-19 antiviral treatment...
By Ahmed Aboulenein WASHINGTON (Reuters) -Rising COVID-19 cases are driving up the use of therapeutics, with Pfizer Inc (NYSE:PFE)'s oral antiviral treatment Paxlovid seeing a 315% jump over the...
By Ahmed Aboulenein WASHINGTON (Reuters) -Use of Pfizer Inc’s COVID-19 oral antiviral treatment Paxlovid has jumped 315% over the past four weeks, the U.S. Department of Health and Human Services said...
By Manas Mishra and Michael Erman (Reuters) -The U.S. Food and Drug Administration on Tuesday authorized the use of a booster shot of Pfizer (NYSE:PFE) and BioNTech's COVID-19 vaccine for children...
By Liz Moyer Investing.com -- Pfizer Inc (NYSE:PFE) shares rose after the Food and Drug Administration approved its Covid-19 booster shot for children aged 5 to 11. Pfizer stock rose 0.6% in...
Kids in the age group can get a Pfizer booster dose at least five months after their second shot.
(Reuters) – The U.S. Food and Drug Administration has authorized the use of a booster shot of Pfizer and BioNTech’s COVID-19 vaccine for children aged 5 to 11, the regulator said on Tuesday.
(Reuters) -U.S. health regulators are expected to authorize a booster shot of Pfizer/BioNTech's COVID-19 vaccine for children aged 5 to 11 as soon as Tuesday, the New York Times reported on Monday,...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review